Coherus BioSciences Inc. (CHRS)
NASDAQ: CHRS
· Real-Time Price · USD
1.04
0.02 (1.96%)
At close: Aug 15, 2025, 3:59 PM
1.02
-2.39%
After-hours: Aug 15, 2025, 07:33 PM EDT
Coherus BioSciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 216.89M | 82.41M | 125.99M | 97.69M | 159.24M | 259.77M | 102.89M | 80.26M | 72.92M | 16.14M | 63.55M | 286.81M | 275.48M | 325.68M | 417.19M | 360.54M | 329.74M | 259.49M |
Short-Term Investments | 20.74M | n/a | n/a | n/a | n/a | n/a | 14.86M | 50.82M | 71.79M | 111.94M | 128.13M | n/a | n/a | n/a | n/a | 108.17M | 124.68M | 140.01M |
Long-Term Investments | n/a | n/a | 263K | 263K | 452K | 452K | 452K | n/a | n/a | n/a | 440K | n/a | n/a | n/a | 440K | n/a | n/a | n/a |
Other Long-Term Assets | 5.04M | 5.66M | 50.2M | 78.49M | 57.68M | 74.32M | 87K | 86.83M | 71.37M | 44.8M | 49.47M | 87.06M | 86.1M | 69.38M | 34.49M | 56.62M | 66.84M | 62.81M |
Receivables | 5.11M | 62.44M | 122.33M | 198.8M | 313.57M | 284.14M | 260.52M | 216.51M | 141.31M | 101.46M | 109.96M | 91.19M | 115.71M | 117.04M | 123.02M | 136.35M | 141.82M | 140.41M |
Inventory | 4.51M | 3.52M | 70.09M | 47.64M | 62.16M | 61.98M | 62.6M | 66.78M | 63.99M | 114.49M | 115.05M | 27.72M | 31.74M | 36.95M | 93.25M | 37.58M | 39.67M | 51.61M |
Other Current Assets | 132.95M | 154.9M | 11.53M | 14.18M | 13.78M | 14.08M | n/a | n/a | 8K | n/a | 22.92M | 21.93M | 16.67M | 19.36M | n/a | 10.03M | 8.94M | 10.35M |
Total Current Assets | 380.2M | 310.18M | 341.58M | 369.02M | 557.93M | 627.48M | 475.63M | 444.37M | 385.48M | 344.03M | 416.7M | 448.27M | 446.78M | 512.44M | 633.47M | 673.04M | 660.01M | 617.26M |
Property-Plant & Equipment | 1.91M | 2.26M | 2.84M | 2.91M | 3.33M | 4.19M | 11.03M | 6.07M | 6.93M | 7.72M | 8.75M | 9.57M | 9.55M | 8M | 7.81M | 8.51M | 9.13M | 9.67M |
Goodwill & Intangibles | 52.31M | 52.98M | 53.65M | 54.31M | 55.45M | 57.1M | 71.67M | 46.52M | 5.81M | 5.87M | 5.93M | 6M | 3.56M | 3.56M | 3.56M | 3.56M | 3.56M | 3.56M |
Total Long-Term Assets | 59.26M | 60.89M | 106.95M | 135.98M | 116.92M | 136.07M | 153.97M | 139.42M | 84.11M | 58.39M | 64.15M | 102.63M | 99.22M | 80.94M | 45.87M | 68.69M | 79.53M | 76.04M |
Total Assets | 439.46M | 371.07M | 448.53M | 505M | 674.86M | 763.54M | 629.6M | 583.78M | 469.59M | 402.43M | 480.85M | 550.91M | 546M | 593.39M | 679.33M | 741.73M | 739.54M | 693.3M |
Account Payables | 37.62M | 40.93M | 28.46M | 21.89M | 76.82M | 38.29M | 35.22M | 37.09M | 29.28M | 23.23M | 11.53M | 9.92M | 17.49M | 21.09M | 16.16M | 45.71M | 14.57M | 15.48M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.45M | n/a | n/a | n/a | n/a | n/a | -86.3M | n/a | n/a | n/a |
Short-Term Debt | 1.76M | 72K | 1.15M | 2.18M | 2.68M | 175M | 2.15M | 4.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 125.28M | 119.01M | 106.99M |
Other Current Liabilities | 213.24M | 46.18M | 31.96M | 269.86M | 142.74M | 22.76M | 1.16M | -429K | n/a | n/a | n/a | n/a | n/a | n/a | 123.66M | n/a | n/a | n/a |
Total Current Liabilities | 263.63M | 255.04M | 282.98M | 295.57M | 463M | 538.3M | 331.77M | 239.66M | 169.44M | 55.7M | 54.46M | 171.32M | 140.75M | 153.75M | 79.03M | 320.35M | 287.05M | 257.6M |
Long-Term Debt | 2.41M | 265.35M | 264.93M | 291.94M | 290.06M | 299.67M | 473.37M | 472.77M | 472.19M | 471.62M | 471.06M | 470.5M | 420.96M | 420.46M | 408.28M | 281.89M | 287.07M | 298.04M |
Other Long-Term Liabilities | 53.6M | 30.19M | 28.23M | 632K | 632K | 1.63M | 11.46M | 3.51M | 102K | 102K | 3.47M | 102K | 102K | 102K | 750K | 750K | 751K | 750K |
Total Long-Term Liabilities | 56.01M | 299.49M | 297.54M | 297.41M | 295.96M | 307.09M | 491.26M | 477.72M | 474.92M | 543.24M | 563.8M | 476.72M | 427.88M | 427.08M | 502.58M | 290.62M | 296.27M | 308.03M |
Total Liabilities | 319.64M | 554.54M | 580.52M | 592.97M | 758.96M | 845.39M | 823.03M | 717.38M | 644.36M | 598.93M | 618.26M | 648.04M | 568.63M | 580.82M | 581.61M | 610.97M | 583.32M | 565.63M |
Total Debt | 2.41M | 269.93M | 269.9M | 299.48M | 298.34M | 481.16M | 480.84M | 478.68M | 479.26M | 471.62M | 471.06M | 480.72M | 431.76M | 430.34M | 408.28M | 418.77M | 417.94M | 417.56M |
Common Stock | 12K | 12K | 12K | 12K | 12K | 11K | 11K | 11K | 9K | 8K | 8K | 7K | 7K | 7K | 7K | 7K | 7K | 7K |
Retained Earnings | -1.31B | -1.61B | -1.55B | -1.5B | -1.49B | -1.48B | -1.58B | -1.5B | -1.46B | -1.42B | -1.34B | -1.28B | -1.2B | -1.15B | -1.05B | -1B | -965.6M | -935.7M |
Comprehensive Income | -275K | -275K | -275K | -275K | -272K | -272K | -248K | -265K | -297K | -278K | -249K | -270K | -270K | -272K | -270K | -273K | -267K | -307K |
Shareholders Equity | 119.83M | -183.47M | -131.99M | -87.97M | -84.11M | -81.84M | -193.43M | -133.6M | -174.76M | -196.51M | -137.42M | -97.13M | -22.63M | 12.56M | 97.73M | 130.76M | 156.22M | 127.67M |
Total Investments | 20.74M | n/a | 263K | 263K | 452K | 452K | 15.31M | 50.82M | 71.79M | 111.94M | 128.13M | n/a | n/a | n/a | 440K | 108.17M | 124.68M | 140.01M |